McKenna's Pharmacology for Nursing, 2e

994

Index

Succinylcholine, 427 Sucralfate, 896, 901, 909 Sulfacetamide, 112, 958 Sulfadiazine, 112 Sulfamethoxazole, 112, 820 Sulfasalazine, 112 Sulfonamides, 91, 112–114 adverse effects, 113 care considerations, 113–114 contraindications and cautions, 112 drug–drug interactions, 113 pharmacokinetics, 112 therapeutic actions and indications, 112 Sulfonylureas, 573, 585–588 adverse effects, 588 contraindications and cautions, 588 drug–drug interactions, 588 first generation, 587 pharmacokinetics, 588 second generation, 587 therapeutic actions and indications, 587–588 Sulindac, 247 Sumatriptan, 398, 411, 412 Sunitinib, 219, 220, 221 Superinfections, 31, 35, 81, 87 Suppressor T cells, 236 Supraventricular arrhythmias, 648 Surfactant, 835, 837 Suxamethonium, 432, 434, 437–438 elderly persons, in, 440–441 Swallowing, 888, 891, 893 Sweet violet flowers, 967 Sympathetic nervous system, 444–449 adrenergic receptors, 448 adrenergic response, 447–449 alpha-receptors, 444, 448 beta-receptors, 444, 448 blockers, 675–676 noradrenaline release, 448 noradrenaline synthesis and storage, 447–448 structure and function, 445–446 termination of response, 449 Sympatholytic drugs, 469, 470 Sympathomimetics, 455, 864, 867, 871–873 adverse effects, 872 care considerations, 872–873 contraindications and cautions, 872 drug–drug interactions, 872 pharmacokinetics, 872 therapeutic actions and indications, 871–872 Synapse, 292, 295–296

Tachycardia, 696, 698 Tachypnoea, 681, 684 Tacrine, 490 Tacrolimus, 260, 263 Tadalafl, 635–637 Tamoxifen, 191, 212, 215–216 Tamsulosin, 475, 828, 829 Tapentadol, 402 Tarragon, 967 Telaprevir, 144, 145 Telbivudine, 144, 145 Telmisartan, 665, 669 Temazepam, 305, 306 Temozolomide, 195, 197 Temsirolimus, 220, 221 Tenecteplase, 757, 764 Teniposide, 209 Tenofovir, 136, 137, 138 Teratogenicity, 2, 6, 38–39 Terazosin, 475, 676, 828, 829 Terbinafine, 151–154, 157, 952 Terbutaline, 465, 867, 871–872 Tazarotene, 953 Tea tree oil, 967 Teicoplanin, 83

Thioguanine, 200, 202 Thiopentone, 416, 419, 420 Thiotepa, 195, 197 Threadworm infections, 180, 181 threadworms, 179 Thrombin, 753–755, 759–760, 766, 768–770 Thromboembolic disorders, 750, 754–755 Thrombolytic agents, 750, 751, 764–766 adverse effects, 765 care considerations, 765–766 contraindications and cautions, 765 drug–drug interactions, 765 pharmacokinetics, 765 therapeutic actions and indications, 764–765 Thyme, 967 Thymosin, 235 Thymus gland, 235 Thyroid and parathyroid agents, 551–570 adults, 554 children, 554 older adults, 554 parathyroid agents, 565–569 antihypercalcaemic agents, 566, 567–569 antihypocalcaemic agents, 565–567 parathyroid glands, 552, 562–565 control, 563 dysfunction, 563 hormones and, 514 hyperparathyroidism, 563 antithyroid agents, 557, 560–562 care considerations, 558, 561–562 thyroid hormones, 556–558 Thyroid gland, 552–556 control, 553 dysfunction, 553–556 hormones and, 514 hypoparathyroidism, 563, 564 structure and function, 562–563 thyroid agents, 556–562

Teriparatide, 565, 566 Testes, 596, 601–602 hormones and, 514 Testosterone, 596, 601–603, 627, 629, 630 Tetanus, 274, 286 Tetanus immune globulin, 286 Tetanus toxoids, 279–280 Tetracyclines, 91, 114–115, 117–118 adverse effects, 115 drug–drug interactions, 115 drug–food interactions, 115 pharmacokinetics, 114 therapeutic actions and indications, 114 Thalidomide, 119 Theophylline, 866–869, 879 toxic reaction to, 869, 870–871 Therapeutic concentration, 16 Therapeutic Goods Administration (TGA), 2, 5 drug evaluation, 5–8 reporting medication errors, 49–50 Therapeutic Guidelines , 12 Therapeutic index, 19–20 Thiazide and thiazide-like diuretics, 658, 805, 807–809 adverse effects, 809 contraindications and cautions, 808–809 drug–drug interactions, 809 pharmacokinetics, 808 therapeutic actions and indications, 807–808 Thiazolidinediones, 573, 587, 588–589 Thioamides, 551, 552 adverse effects, 561 drug–drug interactions, 561 pharmacokinetics, 560 therapeutic actions and indications, 560 care considerations, 117–118 contraindications and cautions, 114–115

hyperthyroidism, 555, 556 hypothyroidism, 554–556

structure and function, 552–553 Thyroid hormones, 552, 556–558 adverse effects, 557 care considerations, 558 contraindications and cautions, 556–557 drug–drug interactions, 557 pharmacokinetics, 556

therapeutic actions and indications, 556 Thyrotropin-releasing hormone (TRH), 522 Thyrotropin alfa, 526, 530 Thyroxine, 551, 552, 556–558 Tiagabine, 354, 365–368

Syncytia, 642, 643 Synergistic, 90, 93 Synthetic drug sources, 5

Systemic arterial pressure, 652 Systemic circulation, 649, 650 Systemic infections, 85 Systole, 642, 644 T

Tiaprofenic acid, 247 Ticagrelor, 756, 758 Ticarcillin, 108, 109 Ticarcillin and clavulanic acid ( Timentin), 93

T cells, 229, 233, 234 suppressors, 263–266

Ticlopidine, 756, 758 Tigecycline, 114, 121